Combined treatment with venetoclax, dasatinib, and FLT3 inhibitors for NUP98‐NSD1+/FLT3‐ITD+ acute myeloid leukemia: A pediatric case report

Pediatric Blood & CancerEarly View e30308 LETTER TO THE EDITOR Combined treatment with venetoclax, dasatinib, and FLT3 inhibitors for NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia: A pediatric case report Xiaojia Wen, Xiaojia Wen orcid.org/0000-0002-0908-3290 Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China National Key Clinical Discipline of Pediatric Hematology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, ChinaSearch for more papers by this authorYing Wu, Ying Wu Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China National Key Clinical Discipline of Pediatric Hematology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, ChinaSearch for more papers by this authorPengli Huang, Pengli Huang Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China National Key Clinical Discipline of Pediatric Hematology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, ChinaSearch for more papers by this authorHuyong Zheng, Corresponding Author Huyong Zheng zhenghuyong@bch.com.cn orcid.org/0000-0002-1484-9131 Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China National Key Clinical Discipline of Pediatric Hematology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China Correspondence Huyong Zheng, Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing 100045, China. Email: zhenghuyong@bch.com.cnSearch for more papers by this author Xiaojia Wen, Xiaojia Wen orcid.org/0000-0002-0908-3290 Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China National Key Clinical Discipline of Pediatric Hematology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, ChinaSearch for more papers by this authorYing Wu, Ying Wu Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China National Key Clinical Discipline of Pediatric Hematology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, ChinaSearch for more papers by this authorPengli Huang, Pengli Huang Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China National Key Clinical Discipline of Pediatric Hematology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, ChinaSearch for more papers by this authorHuyong Zheng, Corresponding Author Huyong Zheng zhenghuyong@bch.com.cn orcid.org/0000-0002-1484-9131 Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China National Key Clinical Discipline of Pediatric Hematology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China Correspondence Huyong Zheng, Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing 100045, China. Email: zhenghuyong@bch.com.cnSearch for more papers by this author First published: 25 March 2023 https://doi.org/10.1002/pbc.30308Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issuee30308 RelatedInformation